Thank you for Making our 11th Annual LDV Vision Summit a Great Success! Check out highlights, videos, insights

/
Thank you for Making our 11th Annual LDV Vision Summit a Great Success! Check out highlights, videos, insights

Our 11th Annual LDV Vision Summit was our most attended event to date, bringing together deep tech entrepreneurs, technologists, academics, researchers and investors for engaging discussions on cutting-edge visual tech and AI innovations. We were thrilled to welcome speakers from Sequoia Capital, NVIDIA, IBM, Kleiner Perkins, Phare Bio, IVP, Mitra Chem, BAM Corner Point, Duke University, Fortune, Argonne National Laboratory, Princeton University, The Pioneer Centre for Artificial Intelligence and Fieldstone Bio. Three of our LDV Capital portfolio companies also presented: Synthesia, DANNCE AI and ResiQuant.

Read More

AI in Insurance: Partnering with ResiQuant to Turn Catastrophe Risk into Resilience with AI-Powered Property Intelligence Platform

/
AI in Insurance: Partnering with ResiQuant to Turn Catastrophe Risk into Resilience with AI-Powered Property Intelligence Platform

We are very excited to partner with the fantastic deep tech team at ResiQuant that is developing a platform that utilizes agentic AI and computer vision to transform data into actionable, building-level insights. This empowers property owners and carriers to mitigate vulnerabilities, streamline workflows and enhance underwriting decisions.

We at LDV Capital led their $4M seed round with participation from Foothill Ventures, Pear VC, Alumni Ventures and angels.

Read More

Partnering With Brilliant People, Delivering Distributions, Recruiting An Analyst & Hopefully Improving Our World

/
Partnering With Brilliant People, Delivering Distributions, Recruiting An Analyst & Hopefully Improving Our World

We are thrilled to share that we have returned our LDV Capital I & II funds. We continue to have significant upside potential across each of our funds thanks to our brilliant entrepreneurs, experts, team and LP partners.

We continue investing out of our LDV Capital IV fund. 

LPs say we are highly differentiated, disciplined, have high-quality sourcing and successfully create value by investing in category leaders at the earliest stages.

We are excited to be recruiting an Analyst to join our team to help us identify, analyze and evaluate investment opportunities. You will be a major contributor to all aspects of our fund from sourcing, market research, due diligence and supporting our portfolio companies.

Read More

3 Years Investing at LDV Capital: Insights from Sourcing, Evaluating & Partnering with Early-Stage Deep Tech Founders

/
3 Years Investing at LDV Capital: Insights from Sourcing, Evaluating & Partnering with Early-Stage Deep Tech Founders

In September 2021, Ash Cleary began his venture capital journey by joining Evan Nisselson and our LDV Capital team as an Analyst, investing out of Fund III as part of a two-year program. After successfully completing the program, Ash was promoted to Associate and now invests out of LDV Capital's fourth fund.

Check out his insights and reflections on the past three years—working with the team and collaborating with brilliant deep tech entrepreneurs worldwide, building businesses powered by visual technology and artificial intelligence.

Read More

Partnering with VitVio to Deliver Real-Time AI Visual Tracking In Hospital Operating Theatres to Increase Efficiencies

/
Partnering with VitVio to Deliver Real-Time AI Visual Tracking In Hospital Operating Theatres to Increase Efficiencies

We are excited to partner and invest in the brilliant VitVio team. They are building an AI-driven computer vision platform designed to enhance the safety and efficiency of hospital operating theaters.

We at LDV Capital led their $2M pre-seed round with participation from Bek Ventures (ex-Earlybird), Tiny Supercomputer Investment Company, and angel investors.

VitVio has also announced their pilot program with the Royal Orthopaedic Hospital (ROH), one of the UK's three leading medical institutions in orthopedic care and “one of the best hospitals in the world.”

Read More

To Be Successful in Business, You Have to Be Contrarian and Right

/
To Be Successful in Business, You Have to Be Contrarian and Right

Evan Nisselson first met Roelof Botha, Managing Partner and Steward of Sequoia Capital, while fundraising for his startup in 2005. Roelof said, “I think back to that meeting we had, and you had a vision for the future and the impact of visual, just imagery on consumer experiences was completely spot on.”

At our 10th Annual LDV Vision Summit, Roelof joined Evan for a fireside chat to discuss trends and early-stage investment opportunities in businesses leveraging visual technologies and AI. They spoke about Roelof’s insights from the ups and downs of the PayPal days, marshmallow tests, personality traits and much more!

Read More

AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

/
AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

DANNCE.AI is bringing to market a novel phenotyping platform to digitize the clinical assessments used by clinicians and drug developers to quantify movement. We led their $2.6M pre-seed round along with co-investors Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio.

Read More

Drug Discoverer Shares Opportunities in Therapeutics & AI

/
Drug Discoverer Shares Opportunities in Therapeutics & AI

Dr. David Rabuka is a serial biotech entrepreneur and investor based in Berkeley California. His expertise is concentrated on translating new technologies into clinical therapies. In 2024, Dr. Rabuka spoke about investment trends & opportunities in ​​life sciences and biotech at our Annual General Meeting. Check out our shortened & lightly edited transcript.

Read More

Visual Technologies Are Fueling the Transition To a Circular Economy

/
Visual Technologies Are Fueling the Transition To a Circular Economy

LDV Capital's Evan Nisselson and Ash Cleary cover topics ranging from spectroscopy and nanomaterials to enhance food and agricultural production, to renewable energy forecasting and grid management, and predictive digital twins for the supply chain.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

/
The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

Meet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.

If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.

Read More

Meta’s Matt Uyttendaele on AI for Material Discovery

/
Meta’s Matt Uyttendaele on AI for Material Discovery

Matt Uyttendaele is the director of the AI for Chemistry group at Meta. His group applies machine learning to material discovery for several applications: clean hydrogen, sorbents for direct air capture, and next-generation displays. In 2024, we were honored to have him speak at our Annual General Meeting about a new application of AI that he has been working on for the last few years and how it relates to his career in visual technologies.

Read More

LDV Community is Helping Each Other Succeed: July 2024 Happy Hour Photos

/
LDV Community is Helping Each Other Succeed: July 2024 Happy Hour Photos

Our LDV platform events bring together the world’s brightest technology innovators, serial entrepreneurs, deep tech researchers and investors to discuss the latest trends in visual tech and AI. Check out a few photographs from our most recent invite-only Happy Hour event hosted in New York City.

Read More

Max Blacker Joins LDV Capital As an Investment Analyst

/
Max Blacker Joins LDV Capital As an Investment Analyst

We are honored to have a fantastic LDV team and community of experts that help us filter, review and advise our portfolio teams that are building valuable businesses powered by visual technologies and AI.

We are thrilled to announce the addition of Max Blacker to our LDV team. We were impressed with his communication style, thoughtful approach and problem-solving skills.

Read More

LDV Capital's Annual General Meeting 2024: The Visual Tech & AI Experts Building The Future

/
LDV Capital's Annual General Meeting 2024: The Visual Tech & AI Experts Building The Future

Our Annual General Meetings (AGM) are exclusive, invite-only events for LDV Capital LPs, portfolio companies, LDV experts and special guests. We are thrilled to share a glimpse of our most recent AGM in New York City, giving you a unique opportunity to see what usually happens behind closed doors.

Read More

120+ Women Spearheading Advances in Visual Tech and AI

/
120+ Women Spearheading Advances in Visual Tech and AI

Since 2012, we have been showcasing brilliant women whose work in visual tech and AI is reshaping business and society. In 2020, we started our “Women Leading Visual Tech” series. We are thrilled to showcase an expanded list of women behind many of the technological innovations that we experience today. Their contributions are extremely valuable to our ecosystem and the world. Our initial list consists of 121 names placed in alphabetical order. It features experts in machine vision, pattern recognition and generative models for digitizing the real world, as well as leaders in quantum hardware, nanophotonics and semiconductors which is the foundation for all the visual tech and AI progress.

Read More

Visual Tech Advancements in Life Sciences & Biotech Paving the Way for Longer and Healthier Lives

/
Visual Tech Advancements in Life Sciences & Biotech Paving the Way for Longer and Healthier Lives

As the biotech industry heavily relies on data filtering, analysis, and sharing, visual technologies play a critical role in detecting and imaging biological systems. This paves the way for the future of life sciences tools, enabling next-generation therapeutics, biomanufacturing, and longevity. At our 10th Annual LDV Vision Summit earlier this year, a panel of experts delved into these topics and explored various critical aspects shaping the future of biotechnology. Check out their insights.

Read More

Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

/
Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

We at LDV Capital celebrated our 10th LDV Vision Summit Anniversary! People from over 30 countries were part of our premier global gathering in visual tech & AI. We were thrilled to welcome speakers from Sequoia Capital, Wellville, Generate:Biomedicines, DCVC Bio, Princeton University, Stanford University, University of California, Nobias Therapeutics, Snap, Future Ventures, Meta, Axios and more. Two of our LDV Capital portfolio companies presented as well: Synthesia and Sonus Microsystems.

Read More

Structuring a Sustainable Future: Visual Technology is Advancing the Discovery & Development of New Materials

/
Structuring a Sustainable Future: Visual Technology is Advancing the Discovery & Development of New Materials

We believe that visual technologies will continue to be the crux of advancements in materials science, across nanomaterials and metamaterials, resulting in the transformation of various industrial, medical and consumer applications. Embedded AI will enable materials to reconfigure themselves autonomously in response to their environment. As sensing abilities and algorithms improve, the full potential of navigating the compositional and configurational possibilities of materials will catalyze widespread transformation for optics, biomarker diagnostics, robotics, 3D printing and more.

Read More

Roelof Botha of Sequoia Says 'To Be Successful in This Business, You Have to Be Contrarian and Right'

/
Roelof Botha of Sequoia Says 'To Be Successful in This Business, You Have to Be Contrarian and Right'

Join our 10th Annual LDV Vision Summit on March 21 and witness the fireside chat between LDV Capital’s Evan Nisselson and Roelof Botha, Managing Partner and Steward of Sequoia Capital. Roelof has spent over 20 years building companies in Silicon Valley. He began within the walls of nascent PayPal and led the company through both its IPO in early 2002 and the subsequent acquisition by eBay. Roelof joined Sequoia in 2003 to help founders build enduring businesses. In 2017, he assumed leadership of Sequoia Capital's US/Europe business and became a Steward of the Sequoia Partnership. Roelof is a Director of 23andMe, Block, Ethos, Inside.com, Landis, mmhmm, MongoDB, Natera, Pendulum Therapeutics, and Unity Technologies, and recently led Sequoia's investment in Meeno. Previously, he was a Director of companies that include YouTube, Tumblr, Xoom, Eventbrite, and Evernote. He also led Sequoia's investment in Instagram.

Roelof and Evan will discuss trends and early-stage investment opportunities in businesses leveraging visual technologies and AI.

Read More

Partnering with Sonus Microsystems to Deliver the Next-Gen Ultrasound For Remote Diagnostic Imaging

/
Partnering with Sonus Microsystems to Deliver the Next-Gen Ultrasound For Remote Diagnostic Imaging

We are thrilled to partner and invest in the brilliant Sonus Microsystems team developing and commercializing a novel and proprietary ultrasound technology that utilizes polymer MEMS sensors to send and receive ultrasonic waves. They are ushering in a new era of ultrasound by commercializing high-performance, custom-designed linear and matrix array transducers for emerging applications in ultrasound imaging.

Read More